Artesunate Suppositories for the Treatment of HIV-negative Patients With Intra-anal HSIL

Clinical trial NCT05555862 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05555862
Sponsor: Frantz Viral Therapeutics, LLC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anal High Grade Squamous Intraepithelial Lesion Anal Precancerous Condition AIN 2/3 HPV Infection Anal Dysplasia HPV Disease

Start date: 2023-02-10
Primary completion: 2026-12-28
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.